ABSTRACT
Leishmaniasis, a disease caused by a protozoan of the genus Leishmania, affects millions of individuals in many regions of the world. Infections by Leishmania braziliensis, the most prevalent species in Brazil, lead to lesions in the skin or mucosa that become cutaneous leishmaniasis (CL) or mucosal leishmaniasis (ML). Cutaneous leishmaniasis lesions start as small papules in the presence or absence of lymphadenopathy, and they progress into one or more skin ulcers. This localized skin ulceration is characterized by a chronic infl ammatory response involving lymphocytes, plasma cells and macrophages, with and an eventual granulomatous reaction and necrosis 1, 2 .
The tissue response in the initial disease manifestation, including early ulcers (≤ 20 days of lesion appearance) and papules from disseminated leishmaniasis (DL), has not been well studied. DL is an emerging form of leishmaniasis that corresponds to 1.9% of all CL cases; it is characterized by the appearance of multiple pleomorphic lesions in more than two noncontiguous areas of the body, starting from a primary ulcer [2] [3] [4] [5] . The mechanisms involved in DL have not been elucidated. It has been suggested that parasite, host and environmental factors may contribute to the dissemination of the parasite throughout the body 5 .
Cluster of differentiation 8 (CD8)+ T cells are essential in the response against viruses and malignant cells, but few studies report the role of these cells in the defense against Leishmania parasites [6] [7] [8] . Although the presence of cluster of differentiation 4 (CD4)+ T cells within the inflammatory infiltrate in leishmaniasis lesions has already been shown, cytotoxic T cells in the lesions of CL patients 6 have also been reported.
The role of CD8+ T cells remains unclear, and contradictory results have been obtained for Leishmania infection; these cells may contribute to the killing of Leishmania or to the immunopathology of this parasite. A signifi cant proportion of CD8+ cells in human leishmaniasis tissue fragments has been reported 9 . The CD8+ lymphocytes could participate in parasite growth control through different mechanisms. These cells have been associated with cure after treatment through interferon gamma (IFN-γ production, and they can also interact directly with Leishmania-infected macrophages by killing them through cytotoxic activity via granzyme granules [10] [11] [12] . Thus, CD8+ T lymphocytes expressing granzyme appear to be important in the immunopathology of leishmaniasis but may also be responsible for the characteristic lesions of CL. Characterization of the cell
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composition and the localization of granzyme B in all types of cutaneous leishmaniasis lesions, including early events in the immune response, may help to elucidate the mechanism of tissue damage.
In the present study, we investigated the proportions of CD8+ T cells and granzyme B+ cells in primary and secondary lesions from DL and in early and late CL lesions to better understand the roles of these cells in the pathogenesis of the disease.
Patients
Thirty patients from Corte de Pedra, an area of Leishmania braziliensis transmission in the State of Bahia, Brazil, were enrolled in this study. A diagnosis of cutaneous leishmaniasis was initially made based on the presence of a typical lesion and a positive Leishmania skin test, and the diagnosis was confi rmed by parasite isolation or identifi cation of amastigote forms by histopathological analysis. Disseminated leishmaniasis was clinically diagnosed based on the presence of multiple (more than 10 lesions in at least two different areas of the body) acneiform, papular or ulcerated lesions. Confi rmation of the diagnosis was performed as established above for CL. Patients were not under treatment at the time of tissue fragment collection. Cases with durations of more than 20 days were classifi ed as late cutaneous lesions (L-CL), and cases with durations of 20 days or less were grouped as early cutaneous lesions (E-CL). For each patient with disseminated leishmaniasis, one tissue fragment was collected from primary ulcers of DL (U-DL), and one was collected from secondary papular lesions of DL (P-DL). Each group of patients consisted of 10 subjects, with a total of 40 tissue fragments. None of the patients had been previously diagnosed with or treated for leishmaniasis.
Tissue fragment collection
Tissue fragments were collected under local anesthesia using a 4mm punch. The specimens were collected from the border of the ulcer and, in case of a secondary lesion in DL, from papules.
The fragments were fi xed in 10% formaldehyde, and the slides were prepared at the histotechnology laboratory at Fundação Oswaldo Cruz (FIOCRUZ). The tissue samples were dehydrated and embedded into paraffi n blocks, and cryosections (4 to 6µm) were placed on silane-pre-coated slides.
Hematoxylin-eosin and immunohistochemistry staining
Sections obtained from paraffi n were routinely deparaffi nized and rehydrated. Slides were stained with hematoxylin-eosin (HE) for histological diagnosis, for infl ammatory infi ltrate analysis and to perform immunohistochemistry (IHC) reactions.
Immunohistochemistry reactions were followed by blocking peroxidase activity with 3% hydrogen peroxide for 5min. The slides were incubated for 30min with anti-CD8 antibody (M3164, Spring Bioscience Corp., Pleasanton, CA, USA) at a dilution of 1:100 at 25°C or overnight with anti-granzyme B (262A-16, Cell Marque Corp., Rocklin, CA, USA) at a dilution of 1:100 at 4°C. Immunostaining was performed using the Peroxidase Mouse & Rabbit Kit -HRP (DBS KP500, US) according to the manufacturer's recommendations. All slides were counter-stained with Harris hematoxylin, dehydrated and mounted with Canadian balsam and glass cover slips.
Morphometric analysis
Images from all HE-stained sections were acquired using an optical microscope (NIKON E-600) coupled to a digital color video camera at 400x magnifi cation. The infl amed area was calculated through measurements of the total fragment and infl ammatory infi ltrate areas. The CD8 and granzyme B expression levels in the infi ltrate were quantifi ed by counting the number of CD8+ T and granzyme B+ cells present in 15 fi elds per fragment. The frequencies of CD8+ and granzyme B+ cells in the papillary and reticular dermis were graded subjectively, and the values indicate the frequency of positive immunostained cells (0, absent; 1, low frequency; 2, medium frequency; 3, high frequency). ImageJ software (National Institute of Mental Health, USA) was used to measure areas and count cells.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 software. The Spearman test was used to analyze correlations of infl ammation between both groups of cells. The KruskalWallis non-parametric test was performed to compare L-CL, E-CL, U-DL and P-DL groups according to the number of CD8+ T and granzyme B+ cells. Differences in the frequencies of immunostained cells in the papillary dermis and the reticular dermis between patient groups were analyzed using the Chisquare test. Results were considered statistically signifi cant when p < 0.05.
Ethical considerations
Informed consent was obtained before the collection of tissue fragments, and all patients received treatment despite their enrollment in this study. The study was approved by the Human Ethics Committee of the Gonçalo Moniz Research Center, FIOCRUZ protocol number 321-2009.
The clinical profi le of the 30 patients is shown in Table 1 , and the clinical characteristics of different lesions are shown in Figure 1 . Twenty-one men and 9 women were enrolled, with a mean age ± standard deviation (SD) of 31.52 ± 16.4 years (ages ranged from 9 to 76 years). The duration of lesions ranged from 25 to 60 days for L-CL (34 ± 10 days), 15 to 20 days for E-CL (17 ± 2 days), 20 to 90 days for U-DL (43 ± 20 days) and 8 to 90 days for P-DL (30 ± 25 days). Lesion size varied from 56 to 750mm 2 for L-CL, 9 to 200mm 2 for E-CL and 56 to 460mm 2 for U-DL. P-DL lesions were not measured, and the median number of lesions for the 10 patients with DL was 30 (range, 2-200 lesions) for papular lesions and 3 (range, 1-15) for ulcerated lesions. Cutaneous leishmaniasis patients presented only 1 lesion (range, 1-2). Histopathological examination of tissue fragments from ulcerated or papular lesions revealed chronic infl ammatory reactions in the tissue fragment sections from all of the clinical forms. In all stages of CL, infl ammation was characterized by the presence of lymphocytes, plasmocytes and macrophages. Other general histopathological patterns were also found in tissue fragments, such as perivascular and papillary edema (45%), necrosis (43%), granuloma (43%), giant cells (30%), rare neutrophils (18%) and pigmentary incontinence (28%).
The localization of cells expressing CD8 and granzyme B in the skin revealed that these cells are mostly in the papillary dermis, next to the epidermis, though the quantity of granzyme B+ cells was lower ( Figure 2) ; the co-localization of the two types of cells was not analyzed. The majority of L-CL lesions (6/10) and U-DL lesions (6/10) were grade 3 (high frequency) for CD8+ frequency in the papillary dermis. Among the recent lesions (E-CL and P-DL), the intensity of stained cells had a greater variation, but a majority of the tissue fragments presented higher numbers of cells in the papillary dermis ( Table 2) . The granzyme B+ cell frequency was classifi ed as grade 2 in the majority of the groups. Only 4 tissue fragments in the CD8+ T cell analysis and 2 in the granzyme B+ analysis had a greater grade in the reticular dermis than the papillary dermis. Cells also appeared in a homogenous distribution (10 to 40% of cases per group).
Comparing the infl ammatory infi ltrate percentage between groups, P-DL lesions had the lowest percentage (median=21%; range 6-38%). A higher percentage of inflammation was present in L-CL (median=37%; range 21-52%) and U-DL (median=34%; range 20-56%) patients ( Figure 3A) .
Analyses of the frequencies of CD8+ and granzyme B+ cells were performed using ImageJ software, which allows manual counting of cells.
CD8 expression, similar to the infi ltrate extension, was increased in late ulcerated lesions compared to recent lesions (papules and lesions present < 20 days), which had low absolute numbers of CD8+ lymphocytes ( Figure 3B ).
To determine the contribution of CD8+ cells in the infl ammatory infi ltrate, the correlation of these cells and the infl ammation percentage was analyzed for each group. Only E-CL (R=0.7; p=0.02) and P-DL (R=0.79; p=0.005) lesions exhibited a correlation between the number of CD8+ T cells and greater infl ammation (not shown).
The papular lesions from DL had a higher frequency of granzyme B+ cells than E-CL lesions (p=0.0302) and a frequency similar to those of late and DL ulcers ( Figure 3C) . Interestingly, only E-CL lesions had a positive correlation between granzyme B+ cells and the infl ammatory infi ltrate (R=0.7; p=0.0216). The analysis of late (R=-0.29; p<0.05) and DL ulcers (R=-0.22; p<0.05) revealed that the higher the infl ammation, the lower the amount of granzyme B+ cells (data not shown).
DISCUSSION
Cutaneous leishmaniasis is the most frequent form of leishmaniasis due to L. braziliensis infection. It is clinically characterized by the presence of single or multiple ulcers with a well-delimited and raised border that can persist for months or heal spontaneously. DL, similar to CL, presents initially with an ulcer and then disseminates throughout the body with multiple acneiform and papular secondary lesions 5 .
CD8+ and granzyme B+ lymphocytes were more frequent in the papillary dermis. Histopathological analysis of tissue fragments showed the presence of spongiosis. The aggregation of both cells in the papillary dermis, sometimes also in the epidermis, seems to lead to injury in the basal layer and may contribute to ulcer formation. Recently, it has been suggested that the movement of T cells through the dermis and epidermis and their permanence in one layer or another correlates with the effector or memory phase of the immune response 13 . This fi nding suggests another mechanism for these cells, which together with cytotoxic activity, may contribute to leishmaniasis immunopathology.
In our study, chronic inflammation was observed in all four types of lesions. DL-P and E-CL together showed less infl ammatory infi ltrate than L-CL and U-DL (although statistical analysis showed no signifi cance). This suggests that infl ammation increases as the lesion progresses. These results are in agreement with those of another study showing that a higher intensity of infl ammation is seen in L-CL lesions than in ulcers from CL in a very initial form (not yet ulcerated) 14 . CD8+ lymphocytes with cytotoxic function seem to execute a cytolytic activity that may be important for tissue destruction with ulcer formation, as is seen in ML, where the same CD8+ T cells seem to be involved in disease exacerbation 17 .
Vieira et al 18 .
showed that both localized CL and papular DL lesions presented a higher frequency of CD8+ T cells than CD4+ T cells in infl ammatory infi ltrates, suggesting that CD8+ cells participate directly in the immune response against parasites, principally by IFN-γ production, which induces macrophage activation 18 . However, CD4+ T cells appear to be the main source of IFN-γ and CD8+ T cells have a principal function of cytotoxicity, contributing to lesion formation 8 . In experimental models, CD8+ T cells have already been shown to be necessary for a protective response and also for the immunopathological development of CL 17 . The evaluation of the presence of cytotoxic activity in infl ammatory infi ltrates revealed that lesions of less than 20 days had lesser quantities of cells expressing granzyme B than late ulcers and ulcers from DL. This result agrees with a previous study that showed granzyme expression was associated with lesion progression 14 . Interestingly, papular lesions from DL showed higher numbers of granzyme B+ cells than early ulcers. The association of DL with mucosal disease due to the rapid dissemination of lesions throughout the body and mucosa and the association of cytotoxic CD8+ T cells to tissue damage in ML have previously been reported 5, 19 . Furthermore, granzyme B does not seem to participate in parasite growth control 8 . The presence of granzyme B+ cells in DL papular lesions is indicative of their role in pathology. Granzyme B seems to participate in lesion progression in E-CL, as the expression of granzyme B and the infl ammation percentage show simultaneous increases in E-CL. In summary, CD8+ T cells and granzyme B+ cells are present in the infl ammatory infi ltrates of CL and DL. Further studies are necessary to elucidate the contribution of these cells to the killing or dissemination of the parasite in Leishmania infections. Their cytotoxic function and specifi c localization may be responsible for tissue destruction and may explain the mechanism of ulceration. Due to the scarcity of patients with the DL form who simultaneously present papules and ulcers, a low number of patients was recruited. Further characterization of the infl ammatory reaction in situ in the two clinical forms and the four-lesion spectrum of human leishmaniasis may help elucidate the role of CD8+ cells and their cytotoxic activity in the immunopathogenesis of this disease.
